• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Biologic Therapy Market Size

    ID: MRFR/HC/0344-CR
    200 Pages
    Rahul Gotadki
    July 2025

    Biologic Therapy Market Research Report By Therapy Type (Monoclonal Antibodies, Vaccines, Cell Therapy, Gene Therapy), By Application (Oncology, Autoimmune Diseases, Infectious Diseases, Cardiovascular Diseases), By Route of Administration (Intravenous, Subcutaneous, Intramuscular), By End-user (Hospitals, Clinics, Home Healthcare), and By Regional (North America, Europe, South America, Asia Pa...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Biologic Therapy Market Infographic

    Purchase Options

    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Summary Table of Contents Segmentation Download PDF

    Biologic Therapy Size

    Biologic Therapy Market Growth Projections and Opportunities

    The biologic therapy marketplace is drastically motivated by using the developing incidence of chronic illnesses such as rheumatoid arthritis, cancer, and inflammatory bowel illnesses. Biologic healing procedures, with their focused method, play a critical function in handling these conditions, driving marketplace demand. The upward push of precision medication and personalized therapies is an awesome market driving force. Biologic treatment options designed to target unique molecular pathways align with the principles of customized medicinal drug, offering tailor-made solutions for individual sufferers. The increasing number of biologic treatment options in oncology contributes notably to the marketplace boom. Targeted biologics are increasingly used in most cancer treatments, demonstrating efficacy with decreased aspect consequences in comparison to standard chemotherapy. Patients regularly decide upon biologic therapies due to their centered motion and ability for progressed outcomes. The shift towards patient-centric care impacts market dynamics as healthcare vendors try to satisfy the possibilities of knowledgeable and empowered sufferers. Stringent regulatory processes and approvals play a critical function in shaping the biologic therapy marketplace. Regulatory help ensures the safety and efficacy of biologic drugs, fostering self-assurance amongst healthcare professionals and patients. The usual upward thrust in healthcare expenditure globally definitely affects the biologic therapy market. These remedies, often priced better than conventional tablets, discover popularity as healthcare budgets expand, taking into account the adoption of superior and powerful treatments. Ongoing improvements in drug shipping technology influence the biologic therapy marketplace. Advances in management strategies, such as subcutaneous injections and oral formulations, enhance patient compliance and luxury, contributing to the marketplace's evolution. The COVID-19 pandemic has underscored the importance of biologic remedies, in particular within the context of immunomodulation. The pandemic has increased studies in this field, similarly emphasizing the function of biologics in addressing infectious sicknesses and immune-associated situations. Strategic collaborations, mergers, and partnerships among pharmaceutical organizations contribute to marketplace consolidation. These alliances leverage the strengths of different entities, fostering innovation and expanding the reach of biologic treatments.

    Biologic Therapy Market Size Graph

    Market Summary

    The Global Biologic Therapy Market is projected to grow from 308.6 USD Billion in 2024 to 450 USD Billion by 2035.

    Key Market Trends & Highlights

    Biologic Therapy Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate of 3.49 percent from 2025 to 2035. By 2035, the market valuation is anticipated to reach 450 USD Billion, indicating robust growth potential. In 2024, the market is valued at 308.6 USD Billion, reflecting a strong foundation for future expansion. Growing adoption of biologic therapies due to increasing prevalence of chronic diseases is a major market driver.

    Market Size & Forecast

    2024 Market Size 308.6 (USD Billion)
    2035 Market Size 450 (USD Billion)
    CAGR (2025-2035) 3.49%
    Largest Regional Market Share in 2024 latin_america)

    Major Players

    <p>Merck &amp; Co., Novartis, Regeneron Pharmaceuticals, Teva Pharmaceutical Industries, Pfizer, Gilead Sciences, Celgene, Amgen, AstraZeneca, Eli Lilly, Sanofi, Johnson &amp; Johnson, Roche, Bristol Myers Squibb, AbbVie</p>

    Market Trends

    Due to a number of factors, the Biologic Therapy Market is expanding significantly. The rising incidence of chronic illnesses including diabetes, cancer, and autoimmune disorders is one of the main factors driving the industry and driving the need for more specialized and efficient treatment choices.

    Furthermore, developments in genetic research and biotechnology are improving the creation of biologic medicines and increasing their accessibility for patients. Because biologic medicines may be customized to each patient's unique profile, enhancing treatment results, the move toward personalized medicine is also very important.

    As businesses concentrate on growing their product lines and breaking into emerging regions, opportunities in the Biologic Therapy Market are growing. As more and more cutting-edge biologics hit the market, regulatory bodies are likewise implementing quicker procedures to get these novel therapies to patients.

    There will probably be more biopharmaceutical discoveries as a result of the growing cooperation between pharmaceutical corporations and research universities. Recent patterns show that biosimilars, which provide an affordable substitute for conventional biologic medicines, are becoming more and more popular.

    This change not only facilitates accessibility but also fosters manufacturer competition, which might result in more reasonably priced treatment alternatives for people everywhere. With the integration of digital health technologies into biologic medicines for improved patient monitoring and adherence, technology has also emerged as a revolutionary element.

    Additionally, the worldwide COVID-19 pandemic has increased attention to biologic medicines, especially in the development of vaccines, underscoring their significance in global health systems. All things considered, the Biologic Therapy Market is expanding and is probably going to keep doing so with further innovation, research, and government backing.

     

    <p>The Global Biologic Therapy Market appears to be experiencing a robust expansion, driven by increasing prevalence of chronic diseases and advancements in biotechnology, which may enhance treatment efficacy and patient outcomes.</p>

    U.S. Food and Drug Administration (FDA)

    Biologic Therapy Market Market Drivers

    Rising Prevalence of Chronic Diseases

    The increasing incidence of chronic diseases such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease significantly drives the Global Biologic Therapy Market Industry. As healthcare systems worldwide grapple with the burden of these conditions, biologic therapies offer targeted treatment options that improve patient outcomes. In 2024, the market is projected to reach 308.6 USD Billion, reflecting the growing demand for innovative therapies. The shift towards personalized medicine further emphasizes the need for biologics, as they are designed to target specific pathways involved in disease progression, thereby enhancing efficacy and reducing side effects.

    Market Segment Insights

    Biologic Therapy Market Therapy Type Insights

    <p>The Biologic Therapy Market segment focusing on Therapy Type revealed significant insights into its structure and growth potential. Monoclonal Antibodies represented a dominant player, with a valuation of 120.0 USD Billion in 2024, projected to increase to 175.0 USD Billion by 2035.</p>

    <p>This segment was crucial due to its extensive application in treating diseases such as cancer and autoimmune disorders, representing majority holding in the market. Vaccines followed closely behind, valued at 80.0 USD Billion in 2024, expected to rise to 115.0 USD Billion by 2035.</p>

    <p>The COVID-19 pandemic has underscored the importance of vaccines, amplifying their role in global health strategies and making this segment a significant contributor to market growth. Cell Therapy was valued at 60.0 USD Billion in 2024 and is expected to reach 85.0 USD Billion by 2035,</p>

    Biologic Therapy Market Application Insights

    <p>Within the domain of Applications, the market is intricately segmented into various categories, including Oncology, Autoimmune Diseases, Infectious Diseases, and Cardiovascular Diseases, each playing a vital role in overall industry dynamics.</p>

    <p>Oncology remains a critical area, driven by the rising prevalence of cancers that necessitate effective treatment options, while Autoimmune Diseases are increasingly receiving attention as awareness and diagnosis improve.</p>

    <p>Infectious Diseases, particularly in light of global health challenges, emphasize the urgency for innovative biologic therapies. Furthermore, Cardiovascular Diseases, being a leading cause of morbidity worldwide, highlight the significance of biologic therapies in developing effective management strategies.</p>

    Biologic Therapy Market Route of Administration Insights

    <p>The Biologic Therapy Market is experiencing notable growth, showcasing its significance in healthcare. Within this market, the Route of Administration plays a critical role in determining the effectiveness and acceptance of therapies.</p>

    <p>Key routes, such as Intravenous, Subcutaneous, and Intramuscular, offer unique advantages that cater to specific patient needs and treatment requirements. Intravenous administration is often favored for its rapid onset and consistent delivery, making it suitable for patients requiring immediate therapeutic effects.</p>

    <p>On the other hand, Subcutaneous administration provides the benefits of self-administration, improving patient compliance and comfort, which is becoming increasingly important in chronic disease management. Intramuscular administration, while less commonly used, still holds its ground for vaccines and certain therapeutic agents.</p>

    Biologic Therapy Market End-user Insights

    <p>The Biologic Therapy Market has shown considerable potential across various End-user categories, notably in Hospitals, Clinics, and Home Healthcare settings. Hospitals are significant due to their extensive infrastructure and capacity to handle complex biologic treatments, which results in a substantial proportion of market demand.</p>

    <p>Clinics also contribute significantly, often providing outpatient services and specialized treatments, thereby enhancing access to biologic therapies for a wider population. Home Healthcare has emerged as a vital sector, addressing the increasing preference for patient-centric care in comfortable environments,</p>

    <p>underlining the shift towards more personalized treatment options. This trend is driven by advancements in technology and an emphasis on managing chronic conditions effectively at home. Additionally, the Biologic Therapy Market statistics reflect a steady growth fueled by the rising prevalence of chronic diseases,</p>

    Get more detailed insights about Biologic Therapy Market Research Report- Global Forecast to 2035

    Regional Insights

    In the Biologic Therapy Market, the regional segment showcased substantial market dynamics. By 2024, the North America region held a significant valuation of 130.0 USD Billion, leading the market and reflecting its advanced healthcare infrastructure and research capabilities.

    Europe followed closely with a valuation of 81.0 USD Billion, notable for its strong regulatory framework and innovative biotech initiatives. The Asia Pacific region, valued at 58.0 USD Billion, was marked by rapid growth in emerging markets and increasing healthcare spending, which positioned it as a rapidly expanding sector.

    South America, valued at 23.0 USD Billion, and the Middle East and Africa, with a valuation of 16.65 USD Billion, faced unique challenges such as regulatory hurdles but are gradually advancing in biologic adoption due to evolving healthcare frameworks.

    Each region contributed to the Biologic Therapy Market statistics, with North America showing majority holding that dominated due to the prevalence of chronic diseases and greater access to biologic therapies, while Europe stood out by driving stringent standards and collaborations.

    Overall, these regional valuations emphasized the significant role each played in shaping market growth and dynamics through unique offerings and challenges.

    Biologic Therapy Market Regional Insights

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Key Players and Competitive Insights

    The Biologic Therapy Market has seen considerable growth over recent years, driven by the increasing prevalence of chronic diseases and a rising demand for innovative treatment options.

    This market is characterized by the development of biopharmaceuticals, which are derived from living organisms and have proven highly effective in treating a variety of conditions, including autoimmune diseases, cancers, and infectious diseases.

    As the industry evolves, competition has intensified, with numerous pharmaceutical companies investing heavily in research and development to create new biologic therapies. The landscape includes a mix of established players and emerging biotech firms,

    all aiming to capture market share through innovative product offerings, strategic partnerships, and extensive clinical trials. Companies in this sector are focused on improving patient outcomes, enhancing treatment accessibility, and addressing unmet medical needs, which further fuels competitive dynamics within the market.

    Merck & Co. has established itself as a significant player in the Biologic Therapy Market, leveraging its strong pipeline of innovative therapies and a well-developed distribution network. The company has a robust portfolio of biologic medications that cater to various therapeutic areas, showcasing its commitment to advancing healthcare.

    Its strengths lie not only in the efficacy and safety of its products but also in its considerable investments in research and development, which have propelled the company to the forefront of biologic innovation. Merck & Co.'s strategic collaborations with academic institutions and other biopharma companies further enhance its market presence,

    allowing the company to stay ahead in the highly competitive landscape. Additionally, its global reach enables Merck & Co. to adapt its strategies across different markets, ensuring that its biologic therapies meet the diverse needs of patients worldwide.

    Novartis is another key competitor in the Biologic Therapy Market, recognized for its extensive product line and strong focus on research and development. The company has a diverse range of biologics aimed at treating various diseases, including oncology, immunology, and ophthalmology.

    Novartis's strengths include its commitment to innovation and high-quality manufacturing standards, which are critical in the biologic sector where precision is paramount. The company has been active in strategic mergers and acquisitions to enhance its capabilities and expand its portfolio, successfully integrating new technologies and therapies that complement its existing offerings.

    Notably, Novartis has made significant strides in gene therapy and cell-based treatments, positioning itself as a leader in cutting-edge therapeutic options. The company's global presence, coupled with its adaptive marketing strategies, strengthens its competitiveness in the market, enabling it to respond effectively to the changing dynamics and growing demands of the biopharmaceutical landscape worldwide.

    Key Companies in the Biologic Therapy Market market include

    Industry Developments

    After losing Humira's exclusivity, AbbVie made a significant move into CAR-T cell and autoimmune medicines when it announced in June 30, 2025, that it would buy Capstan Therapeutics for up to $2.1 billion in cash.

    Building on previous purchases, such as Gracell in late 2023, AstraZeneca agreed on March 17, 2025, to acquire EsoBiotec for up to $1 billion, including $425 million up front and $575 million in milestones, to strengthen its cancer and autoimmune cell therapy portfolio.

    The incidence of chronic diseases, biotech innovation, and strategic industrial partnerships continue to be major growth drivers, according to experts' May 23, 2025, projections of the global biologics market, which are expected to expand at a rate of 10–12% through 2029.

    Dr. Vinay Prasad, a well-known opponent of rapid approvals, was named director of the U.S. FDA's Center for Biologics Evaluation and Research on May 6, 2025. This appointment is expected to improve the standard of evidence for new biologic approvals globally.

    The growing biosimilar landscape in immunology is further highlighted by the approval of Pyzchiva®, a ustekinumab biosimilar, by the European Commission in December 2024 and the marketing authorization of Usymro, another ustekinumab copycat, by the EMA's CHMP in June 2025.

    Future Outlook

    Biologic Therapy Market Future Outlook

    <p>The Global Biologic Therapy Market is projected to grow at a 3.49% CAGR from 2024 to 2035, driven by advancements in personalized medicine, increasing prevalence of chronic diseases, and regulatory support for innovative therapies.</p>

    New opportunities lie in:

    • <p>Develop targeted biologics for rare diseases to capture niche markets. Invest in biosimilars to enhance market share and reduce treatment costs. Leverage digital health technologies to improve patient adherence and outcomes.</p>

    <p>By 2035, the market is expected to exhibit robust growth, reflecting evolving therapeutic landscapes and increased patient access.</p>

    Market Segmentation

    Biologic Therapy Market End-user Outlook

    • Hospitals
    • Clinics
    • Home Healthcare

    Biologic Therapy Market Regional Outlook

    • North America
    • Europe
    • South America
    • Asia Pacific
    • Middle East and Africa

    Biologic Therapy Market Application Outlook

    • Oncology
    • Autoimmune Diseases
    • Infectious Diseases
    • Cardiovascular Diseases

    Biologic Therapy Market Therapy Type Outlook

    • Monoclonal Antibodies
    • Vaccines
    • Cell Therapy
    • Gene Therapy

    Biologic Therapy Market Route of Administration Outlook

    • Intravenous
    • Subcutaneous
    • Intramuscular

    Report Scope

    Report Attribute/MetricDetails
    Market Size 2023298.24(USD Billion)
    Market Size 2024308.65(USD Billion)
    Market Size 2035450.0(USD Billion)
    Compound Annual Growth Rate (CAGR)3.49% (2025 - 2035)
    Report CoverageRevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year2024
    Market Forecast Period2025 - 2035
    Historical Data2019 - 2024
    Market Forecast UnitsUSD Billion
    Key Companies ProfiledMerck & Co., Novartis, Regeneron Pharmaceuticals, Teva Pharmaceutical Industries, Pfizer, Gilead Sciences, Celgene, Amgen, AstraZeneca, Eli Lilly, Sanofi, Johnson & Johnson, Roche, BristolMyers Squibb, AbbVie
    Segments CoveredTherapy Type, Application, Route of Administration, End-user, Regional
    Key Market OpportunitiesIncreasing demand for personalized medicine, Expansion of biosimilars market, Advancements in drug delivery systems, Growing prevalence of chronic diseases, Rise in R&D investments.
    Key Market DynamicsIncreasing prevalence of chronic diseases, Growing demand for personalized medicine, Advancements in biotechnology, High cost of treatment, Regulatory challenges and approvals
    Countries CoveredNorth America, Europe, APAC, South America, MEA

    Market Highlights

    Author

    Rahul Gotadki
    Assistant Manager

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM
    View All

    FAQs

    What was the market size of the Biologic Therapy Market in 2024?

    The Biologic Therapy Market was valued at 308.65 USD Billion in 2024.

    What will be the market valuation of the Biologic Therapy Market by 2035?

    By 2035, the Biologic Therapy Market is projected to reach a valuation of around 450.0 USD Billion.

    What is the expected CAGR for the Biologic Therapy Market from 2025 to 2035?

    The expected CAGR for the Biologic Therapy Market from 2025 to 2035 is 3.49%.

    Which region dominated the Biologic Therapy Market in 2024?

    North America dominated the Biologic Therapy Market with a value of 130.0 USD Billion in 2024.

    What will be the market size for Monoclonal Antibodies in 2035?

    The market size for Monoclonal Antibodies is expected to reach 175.0 USD Billion by 2035.

    How much is the Asia Pacific region expected to contribute to the Biologic Therapy Market by 2035?

    The Asia Pacific region is anticipated to contribute approximately 85.0 USD Billion to the Biologic Therapy Market by 2035.

    Who are some of the key players in the Biologic Therapy Market?

    Key players in the Biologic Therapy Market include Merck &amp; Co., Novartis, Regeneron Pharmaceuticals, and Pfizer.

    What was the market size of the vaccine segment in 2024?

    The vaccine segment of the Biologic Therapy Market was valued at 80.0 USD Billion in 2024.

    What are the projected values for the Cell Therapy market from 2024 to 2035?

    The Cell Therapy market is projected to grow from 60.0 USD Billion in 2024 to 85.0 USD Billion by 2035.

    What challenges might the Biologic Therapy Market face over the upcoming years?

    The Biologic Therapy Market may face challenges due to increasing regulatory pressures and competition among emerging therapies.

    1. --- "
    2. Table of Contents
    3. EXECUTIVE SUMMARY
    4. Market Overview
    5. Key Findings
    6. Market Segmentation
    7. Competitive Landscape
    8. Challenges and Opportunities
    9. Future Outlook
    10. MARKET INTRODUCTION
    11. Definition
    12. Scope of the study
    13. Research Objective
    14. Assumption
    15. Limitations
    16. RESEARCH METHODOLOGY
    17. Overview
    18. Data Mining
    19. Secondary Research
    20. Primary Research
    21. Primary Interviews and Information Gathering Process
    22. Breakdown of Primary Respondents
    23. Forecasting Model
    24. Market Size Estimation
    25. Bottom-Up Approach
    26. Top-Down Approach
    27. Data Triangulation
    28. Validation
    29. MARKET DYNAMICS
    30. Overview
    31. Drivers
    32. Restraints
    33. Opportunities
    34. MARKET FACTOR ANALYSIS
    35. Value chain Analysis
    36. Porter's Five Forces Analysis
    37. Bargaining Power of Suppliers
    38. Bargaining Power of Buyers
    39. Threat of New Entrants
    40. Threat of Substitutes
    41. Intensity of Rivalry
    42. COVID-19 Impact Analysis
    43. Market Impact Analysis
    44. Regional Impact
    45. Opportunity and Threat Analysis
    46. Biologic Therapy Market, BY Therapy Type (USD Billion)
    47. Monoclonal Antibodies
    48. Vaccines
    49. Cell Therapy
    50. Gene Therapy
    51. Biologic Therapy Market, BY Application (USD Billion)
    52. Oncology
    53. Autoimmune Diseases
    54. Infectious Diseases
    55. Cardiovascular Diseases
    56. Biologic Therapy Market, BY Route of Administration (USD Billion)
    57. Intravenous
    58. Subcutaneous
    59. Intramuscular
    60. Biologic Therapy Market, BY End User (USD Billion)
    61. Hospitals
    62. Clinics
    63. Home Healthcare
    64. Biologic Therapy Market, BY Regional (USD Billion)
    65. North America
    66. US
    67. Canada
    68. Europe
    69. Germany
    70. UK
    71. France
    72. Russia
    73. Italy
    74. Spain
    75. Rest of Europe
    76. APAC
    77. China
    78. India
    79. Japan
    80. South Korea
    81. Malaysia
    82. Thailand
    83. Indonesia
    84. Rest of APAC
    85. South America
    86. Brazil
    87. Mexico
    88. Argentina
    89. Rest of South America
    90. MEA
    91. GCC Countries
    92. South Africa
    93. Rest of MEA
    94. Competitive Landscape
    95. Overview
    96. Competitive Analysis
    97. Market share Analysis
    98. Major Growth Strategy in the Biologic Therapy Market
    99. Competitive Benchmarking
    100. Leading Players in Terms of Number of Developments in the Biologic Therapy Market
    101. Key developments and growth strategies
    102. New Product Launch/Service Deployment
    103. Merger & Acquisitions
    104. Joint Ventures
    105. Major Players Financial Matrix
    106. Sales and Operating Income
    107. Major Players R&D Expenditure. 2023
    108. Company Profiles
    109. Merck and Co
    110. Financial Overview
    111. Products Offered
    112. Key Developments
    113. SWOT Analysis
    114. Key Strategies
    115. Pfizer
    116. Financial Overview
    117. Products Offered
    118. Key Developments
    119. SWOT Analysis
    120. Key Strategies
    121. Takeda Pharmaceutical
    122. Financial Overview
    123. Products Offered
    124. Key Developments
    125. SWOT Analysis
    126. Key Strategies
    127. AbbVie
    128. Financial Overview
    129. Products Offered
    130. Key Developments
    131. SWOT Analysis
    132. Key Strategies
    133. Roche
    134. Financial Overview
    135. Products Offered
    136. Key Developments
    137. SWOT Analysis
    138. Key Strategies
    139. Gilead Sciences
    140. Financial Overview
    141. Products Offered
    142. Key Developments
    143. SWOT Analysis
    144. Key Strategies
    145. Johnson and Johnson
    146. Financial Overview
    147. Products Offered
    148. Key Developments
    149. SWOT Analysis
    150. Key Strategies
    151. Bristol Myers Squibb
    152. Financial Overview
    153. Products Offered
    154. Key Developments
    155. SWOT Analysis
    156. Key Strategies
    157. Eli Lilly
    158. Financial Overview
    159. Products Offered
    160. Key Developments
    161. SWOT Analysis
    162. Key Strategies
    163. Biogen
    164. Financial Overview
    165. Products Offered
    166. Key Developments
    167. SWOT Analysis
    168. Key Strategies
    169. Novartis
    170. Financial Overview
    171. Products Offered
    172. Key Developments
    173. SWOT Analysis
    174. Key Strategies
    175. Regeneron Pharmaceuticals
    176. Financial Overview
    177. Products Offered
    178. Key Developments
    179. SWOT Analysis
    180. Key Strategies
    181. AstraZeneca
    182. Financial Overview
    183. Products Offered
    184. Key Developments
    185. SWOT Analysis
    186. Key Strategies
    187. Amgen
    188. Financial Overview
    189. Products Offered
    190. Key Developments
    191. SWOT Analysis
    192. Key Strategies
    193. Sanofi
    194. Financial Overview
    195. Products Offered
    196. Key Developments
    197. SWOT Analysis
    198. Key Strategies
    199. Appendix
    200. References
    201. Related Reports

    Biologic Therapy Market Segmentation

    Biologic Therapy Market By Therapy Type (USD Billion, 2019-2035)

    Monoclonal Antibodies

    Vaccines

    Cell Therapy

    Gene Therapy

    Biologic Therapy Market By Application (USD Billion, 2019-2035)

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Cardiovascular Diseases

    Biologic Therapy Market By Route of Administration (USD Billion, 2019-2035)

    Intravenous

    Subcutaneous

    Intramuscular

    Biologic Therapy Market By End User (USD Billion, 2019-2035)

    Hospitals

    Clinics

    Home Healthcare

    Biologic Therapy Market By Regional (USD Billion, 2019-2035)

    North America

    Europe

    South America

    Asia Pacific

    Middle East and Africa

    Biologic Therapy Market Regional Outlook (USD Billion, 2019-2035)

    North America Outlook (USD Billion, 2019-2035)

    North America Biologic Therapy Market by Therapy Type

    Monoclonal Antibodies

    Vaccines

    Cell Therapy

    Gene Therapy

    North America Biologic Therapy Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Cardiovascular Diseases

    North America Biologic Therapy Market by Route of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    North America Biologic Therapy Market by End User Type

    Hospitals

    Clinics

    Home Healthcare

    North America Biologic Therapy Market by Regional Type

    US

    Canada

    US Outlook (USD Billion, 2019-2035)

    US Biologic Therapy Market by Therapy Type

    Monoclonal Antibodies

    Vaccines

    Cell Therapy

    Gene Therapy

    US Biologic Therapy Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Cardiovascular Diseases

    US Biologic Therapy Market by Route of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    US Biologic Therapy Market by End User Type

    Hospitals

    Clinics

    Home Healthcare

    CANADA Outlook (USD Billion, 2019-2035)

    CANADA Biologic Therapy Market by Therapy Type

    Monoclonal Antibodies

    Vaccines

    Cell Therapy

    Gene Therapy

    CANADA Biologic Therapy Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Cardiovascular Diseases

    CANADA Biologic Therapy Market by Route of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    CANADA Biologic Therapy Market by End User Type

    Hospitals

    Clinics

    Home Healthcare

    Europe Outlook (USD Billion, 2019-2035)

    Europe Biologic Therapy Market by Therapy Type

    Monoclonal Antibodies

    Vaccines

    Cell Therapy

    Gene Therapy

    Europe Biologic Therapy Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Cardiovascular Diseases

    Europe Biologic Therapy Market by Route of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    Europe Biologic Therapy Market by End User Type

    Hospitals

    Clinics

    Home Healthcare

    Europe Biologic Therapy Market by Regional Type

    Germany

    UK

    France

    Russia

    Italy

    Spain

    Rest of Europe

    GERMANY Outlook (USD Billion, 2019-2035)

    GERMANY Biologic Therapy Market by Therapy Type

    Monoclonal Antibodies

    Vaccines

    Cell Therapy

    Gene Therapy

    GERMANY Biologic Therapy Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Cardiovascular Diseases

    GERMANY Biologic Therapy Market by Route of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    GERMANY Biologic Therapy Market by End User Type

    Hospitals

    Clinics

    Home Healthcare

    UK Outlook (USD Billion, 2019-2035)

    UK Biologic Therapy Market by Therapy Type

    Monoclonal Antibodies

    Vaccines

    Cell Therapy

    Gene Therapy

    UK Biologic Therapy Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Cardiovascular Diseases

    UK Biologic Therapy Market by Route of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    UK Biologic Therapy Market by End User Type

    Hospitals

    Clinics

    Home Healthcare

    FRANCE Outlook (USD Billion, 2019-2035)

    FRANCE Biologic Therapy Market by Therapy Type

    Monoclonal Antibodies

    Vaccines

    Cell Therapy

    Gene Therapy

    FRANCE Biologic Therapy Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Cardiovascular Diseases

    FRANCE Biologic Therapy Market by Route of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    FRANCE Biologic Therapy Market by End User Type

    Hospitals

    Clinics

    Home Healthcare

    RUSSIA Outlook (USD Billion, 2019-2035)

    RUSSIA Biologic Therapy Market by Therapy Type

    Monoclonal Antibodies

    Vaccines

    Cell Therapy

    Gene Therapy

    RUSSIA Biologic Therapy Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Cardiovascular Diseases

    RUSSIA Biologic Therapy Market by Route of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    RUSSIA Biologic Therapy Market by End User Type

    Hospitals

    Clinics

    Home Healthcare

    ITALY Outlook (USD Billion, 2019-2035)

    ITALY Biologic Therapy Market by Therapy Type

    Monoclonal Antibodies

    Vaccines

    Cell Therapy

    Gene Therapy

    ITALY Biologic Therapy Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Cardiovascular Diseases

    ITALY Biologic Therapy Market by Route of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    ITALY Biologic Therapy Market by End User Type

    Hospitals

    Clinics

    Home Healthcare

    SPAIN Outlook (USD Billion, 2019-2035)

    SPAIN Biologic Therapy Market by Therapy Type

    Monoclonal Antibodies

    Vaccines

    Cell Therapy

    Gene Therapy

    SPAIN Biologic Therapy Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Cardiovascular Diseases

    SPAIN Biologic Therapy Market by Route of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    SPAIN Biologic Therapy Market by End User Type

    Hospitals

    Clinics

    Home Healthcare

    REST OF EUROPE Outlook (USD Billion, 2019-2035)

    REST OF EUROPE Biologic Therapy Market by Therapy Type

    Monoclonal Antibodies

    Vaccines

    Cell Therapy

    Gene Therapy

    REST OF EUROPE Biologic Therapy Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Cardiovascular Diseases

    REST OF EUROPE Biologic Therapy Market by Route of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    REST OF EUROPE Biologic Therapy Market by End User Type

    Hospitals

    Clinics

    Home Healthcare

    APAC Outlook (USD Billion, 2019-2035)

    APAC Biologic Therapy Market by Therapy Type

    Monoclonal Antibodies

    Vaccines

    Cell Therapy

    Gene Therapy

    APAC Biologic Therapy Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Cardiovascular Diseases

    APAC Biologic Therapy Market by Route of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    APAC Biologic Therapy Market by End User Type

    Hospitals

    Clinics

    Home Healthcare

    APAC Biologic Therapy Market by Regional Type

    China

    India

    Japan

    South Korea

    Malaysia

    Thailand

    Indonesia

    Rest of APAC

    CHINA Outlook (USD Billion, 2019-2035)

    CHINA Biologic Therapy Market by Therapy Type

    Monoclonal Antibodies

    Vaccines

    Cell Therapy

    Gene Therapy

    CHINA Biologic Therapy Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Cardiovascular Diseases

    CHINA Biologic Therapy Market by Route of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    CHINA Biologic Therapy Market by End User Type

    Hospitals

    Clinics

    Home Healthcare

    INDIA Outlook (USD Billion, 2019-2035)

    INDIA Biologic Therapy Market by Therapy Type

    Monoclonal Antibodies

    Vaccines

    Cell Therapy

    Gene Therapy

    INDIA Biologic Therapy Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Cardiovascular Diseases

    INDIA Biologic Therapy Market by Route of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    INDIA Biologic Therapy Market by End User Type

    Hospitals

    Clinics

    Home Healthcare

    JAPAN Outlook (USD Billion, 2019-2035)

    JAPAN Biologic Therapy Market by Therapy Type

    Monoclonal Antibodies

    Vaccines

    Cell Therapy

    Gene Therapy

    JAPAN Biologic Therapy Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Cardiovascular Diseases

    JAPAN Biologic Therapy Market by Route of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    JAPAN Biologic Therapy Market by End User Type

    Hospitals

    Clinics

    Home Healthcare

    SOUTH KOREA Outlook (USD Billion, 2019-2035)

    SOUTH KOREA Biologic Therapy Market by Therapy Type

    Monoclonal Antibodies

    Vaccines

    Cell Therapy

    Gene Therapy

    SOUTH KOREA Biologic Therapy Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Cardiovascular Diseases

    SOUTH KOREA Biologic Therapy Market by Route of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    SOUTH KOREA Biologic Therapy Market by End User Type

    Hospitals

    Clinics

    Home Healthcare

    MALAYSIA Outlook (USD Billion, 2019-2035)

    MALAYSIA Biologic Therapy Market by Therapy Type

    Monoclonal Antibodies

    Vaccines

    Cell Therapy

    Gene Therapy

    MALAYSIA Biologic Therapy Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Cardiovascular Diseases

    MALAYSIA Biologic Therapy Market by Route of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    MALAYSIA Biologic Therapy Market by End User Type

    Hospitals

    Clinics

    Home Healthcare

    THAILAND Outlook (USD Billion, 2019-2035)

    THAILAND Biologic Therapy Market by Therapy Type

    Monoclonal Antibodies

    Vaccines

    Cell Therapy

    Gene Therapy

    THAILAND Biologic Therapy Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Cardiovascular Diseases

    THAILAND Biologic Therapy Market by Route of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    THAILAND Biologic Therapy Market by End User Type

    Hospitals

    Clinics

    Home Healthcare

    INDONESIA Outlook (USD Billion, 2019-2035)

    INDONESIA Biologic Therapy Market by Therapy Type

    Monoclonal Antibodies

    Vaccines

    Cell Therapy

    Gene Therapy

    INDONESIA Biologic Therapy Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Cardiovascular Diseases

    INDONESIA Biologic Therapy Market by Route of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    INDONESIA Biologic Therapy Market by End User Type

    Hospitals

    Clinics

    Home Healthcare

    REST OF APAC Outlook (USD Billion, 2019-2035)

    REST OF APAC Biologic Therapy Market by Therapy Type

    Monoclonal Antibodies

    Vaccines

    Cell Therapy

    Gene Therapy

    REST OF APAC Biologic Therapy Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Cardiovascular Diseases

    REST OF APAC Biologic Therapy Market by Route of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    REST OF APAC Biologic Therapy Market by End User Type

    Hospitals

    Clinics

    Home Healthcare

    South America Outlook (USD Billion, 2019-2035)

    South America Biologic Therapy Market by Therapy Type

    Monoclonal Antibodies

    Vaccines

    Cell Therapy

    Gene Therapy

    South America Biologic Therapy Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Cardiovascular Diseases

    South America Biologic Therapy Market by Route of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    South America Biologic Therapy Market by End User Type

    Hospitals

    Clinics

    Home Healthcare

    South America Biologic Therapy Market by Regional Type

    Brazil

    Mexico

    Argentina

    Rest of South America

    BRAZIL Outlook (USD Billion, 2019-2035)

    BRAZIL Biologic Therapy Market by Therapy Type

    Monoclonal Antibodies

    Vaccines

    Cell Therapy

    Gene Therapy

    BRAZIL Biologic Therapy Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Cardiovascular Diseases

    BRAZIL Biologic Therapy Market by Route of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    BRAZIL Biologic Therapy Market by End User Type

    Hospitals

    Clinics

    Home Healthcare

    MEXICO Outlook (USD Billion, 2019-2035)

    MEXICO Biologic Therapy Market by Therapy Type

    Monoclonal Antibodies

    Vaccines

    Cell Therapy

    Gene Therapy

    MEXICO Biologic Therapy Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Cardiovascular Diseases

    MEXICO Biologic Therapy Market by Route of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    MEXICO Biologic Therapy Market by End User Type

    Hospitals

    Clinics

    Home Healthcare

    ARGENTINA Outlook (USD Billion, 2019-2035)

    ARGENTINA Biologic Therapy Market by Therapy Type

    Monoclonal Antibodies

    Vaccines

    Cell Therapy

    Gene Therapy

    ARGENTINA Biologic Therapy Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Cardiovascular Diseases

    ARGENTINA Biologic Therapy Market by Route of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    ARGENTINA Biologic Therapy Market by End User Type

    Hospitals

    Clinics

    Home Healthcare

    REST OF SOUTH AMERICA Outlook (USD Billion, 2019-2035)

    REST OF SOUTH AMERICA Biologic Therapy Market by Therapy Type

    Monoclonal Antibodies

    Vaccines

    Cell Therapy

    Gene Therapy

    REST OF SOUTH AMERICA Biologic Therapy Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Cardiovascular Diseases

    REST OF SOUTH AMERICA Biologic Therapy Market by Route of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    REST OF SOUTH AMERICA Biologic Therapy Market by End User Type

    Hospitals

    Clinics

    Home Healthcare

    MEA Outlook (USD Billion, 2019-2035)

    MEA Biologic Therapy Market by Therapy Type

    Monoclonal Antibodies

    Vaccines

    Cell Therapy

    Gene Therapy

    MEA Biologic Therapy Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Cardiovascular Diseases

    MEA Biologic Therapy Market by Route of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    MEA Biologic Therapy Market by End User Type

    Hospitals

    Clinics

    Home Healthcare

    MEA Biologic Therapy Market by Regional Type

    GCC Countries

    South Africa

    Rest of MEA

    GCC COUNTRIES Outlook (USD Billion, 2019-2035)

    GCC COUNTRIES Biologic Therapy Market by Therapy Type

    Monoclonal Antibodies

    Vaccines

    Cell Therapy

    Gene Therapy

    GCC COUNTRIES Biologic Therapy Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Cardiovascular Diseases

    GCC COUNTRIES Biologic Therapy Market by Route of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    GCC COUNTRIES Biologic Therapy Market by End User Type

    Hospitals

    Clinics

    Home Healthcare

    SOUTH AFRICA Outlook (USD Billion, 2019-2035)

    SOUTH AFRICA Biologic Therapy Market by Therapy Type

    Monoclonal Antibodies

    Vaccines

    Cell Therapy

    Gene Therapy

    SOUTH AFRICA Biologic Therapy Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Cardiovascular Diseases

    SOUTH AFRICA Biologic Therapy Market by Route of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    SOUTH AFRICA Biologic Therapy Market by End User Type

    Hospitals

    Clinics

    Home Healthcare

    REST OF MEA Outlook (USD Billion, 2019-2035)

    REST OF MEA Biologic Therapy Market by Therapy Type

    Monoclonal Antibodies

    Vaccines

    Cell Therapy

    Gene Therapy

    REST OF MEA Biologic Therapy Market by Application Type

    Oncology

    Autoimmune Diseases

    Infectious Diseases

    Cardiovascular Diseases

    REST OF MEA Biologic Therapy Market by Route of Administration Type

    Intravenous

    Subcutaneous

    Intramuscular

    REST OF MEA Biologic Therapy Market by End User Type

    Hospitals

    Clinics

    Home Healthcare

    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Related Reports

    Regional Reports
    Country Reports

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials
    Global Magnesium Sulfate Market – Forecast till 2027